title: [Comparison of 50 mg and 900 mg/day acetylsalicylic acid for prevention of recurrence after percutaneous transluminal angioplasty of the lower extremities: results of the LARA study].
authors: Abteilungen Angiologie, Medizinischen Hochschule Hannover.
authors: C
authors: C
authors: Ranke
authors: A
authors: A
authors: Creutzig
authors: G
authors: G
authors: Luska
authors: H H
authors: HH
authors: Wagner
authors: M
authors: M
authors: Galanski
authors: J C
authors: JC
authors: Frölich
authors: H J
authors: HJ
authors: Avenarius
authors: H
authors: H
authors: Hecker
authors: K
authors: K
authors: Alexander
mesh_terms: D000368:Aged; D000800:Angioplasty, Balloon; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging / Q000628:therapy*; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007511:Ischemia / Q000000981:diagnostic imaging / Q000628:therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011859:Radiography; D012008:Recurrence
chemical_list: D001241:Aspirin
vernacular_title: Vergleich von 50 mg und 900 mg/Tag Acetylsalicylsäure zur Rezidiv-prophylaxe nach perkutaner transluminaler Angioplastie (PTA) der unteren Extremitäten: Ergebnisse der LARA-Studie.